Category Archives: Social media and healthcare

The risk in social media is in being left behind by pharma

The exposure social media provides is potentially priceless – especially when compared to other promotional channels. To stay up-to-date, companies are adapting their communication strategies and embracing these changes. However the risk in the social media field is in being left behind by the prescription drug industry. Continue reading

What is the value of social media in DTC marketing ?

Now that the FDA is essentially letting drug companies “regulate themselves” when it comes to social media I’m sure there are going to be a lot of meetings to discuss the risks vs. benefits.  The first question DTC marketers should ask is “do consumers want to have a social media relationship around this health condition/product?”   Continue reading

DTC Marketers: You can’t measure the ROI of EVERY conversation

No doubt that a lot of marketing people within pharma are going to be spending endless hours, meetings and Power Points trying to justify a dip in the social media marketing water.  Well, you can’t put an ROI around EVERY conversation and to try and do so is a huge waste of time driven by people who don’t understand marketing with people instead of selling them. Continue reading

Social media is a competitive advantage for drug companies

For those of you who are so risk averse that you have decided not to integrate social media into your DTC marketing you are at a competitive disadvantage. Companies that are taking the leap, like Sanofi, are not only learning by doing they are, more importantly, listening via social media and what they hear can lead to a better position with patients in a very competitive marketplace. Continue reading

Minimizing social media risks with new (ah-em) FDA guidelines

For those of you who were expecting hard FDA guidelines on social media marketing there is a bridge I would like to sell you .   Frankly, what the FDA has said is that social media is evolving too fast for us to issue guidelines and and we don’t really understand how consumers are using it for healthcare decisions and information.  Here are the ways to minimize risk with social media marketing for pharma. Continue reading

The FDA gets it right on social media marketing

Social media means more than marketing products. It means using this “emerging electronic media” to advance the public health by communicating factual and timely information.  Damn right ! But will pharma marketers get the message ? Continue reading

Sanofi continues to embrace social media

There are some drug companies that “get it” and understand the need to interact with patients rather than just push information to them.  Sanofi is one of them.  Their latest effort around “Why Insulin” is a great example of an integrated social media strategy to reach diabetics and I believe it raises the bar when it comes to DTC marketing. Continue reading

STOP ! Social media is not the answer

In an era where most consumers do not want to connect with drug companies on social media and where most drug companies don’t have the resources to talk to people via social media I am amazed at how people within the drug industry continue to trumpet social media marketing.  Social media is not the answer because that is not the question that consumers and customers are asking. Continue reading

Pharma & Social Media: Who is the voice of the brand ?

While we continue to count the number or pages that have been removed from Facebook by pharma companies we seem to overlooking another key question: “Who, within the pharma organization, has the skills and knowledge to talk to consumers and be the voice of the brand on social media ?”  Is it PR ?  Is it marketing ?  Is it someone within medical ?  Probably a little bit of everything which is why the biopharma organizations needs a new position created to communicate with consumers via social media. Continue reading

Saluting the pharma social media pioneers

While some people, mostly agency people, have been playing tapps for the removal of Facebook branded pages there are still some pharma pioneers (thank you John Mack) who are moving forward with social network marketing.  The folks at Sanofi and AZ to name a few continue to experiment with social media and they should be featured at the next social media conference, not for what they did, but to share how they won over legal,regulatory and management. Continue reading

Quick survey: Why are you deleting your Facebook page

I contacted 5 brands that took down their Facebook pages today for a quick survey and found that the number one reason they were taking their pages down was “too much risk”.  When I inquired whether they had heard about some new tools that allowed them to manage risk the answers were “no”.  However what I also heard was “it’s just not worth the investment right now in people and other resources”.   Continue reading